Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies

Top 10 Countries for Natural Gas Production (Updated 2024)

7 Biggest Lithium-mining Companies

Copper Price Update: Q1 2024 in Review

A State-by-State Guide to Cannabis in Australia

Trending Press Releases

European Lithium to Acquire Leinster Lithium Project in Ireland with CRML Shares

Energy Fuels Announces Agreement for Transformational Acquisition of Base Resources, Creating a Global Leader in Critical Minerals Production with a Focus on Uranium, Rare Earth Elements and Heavy Mineral Sands

SOURCE ROCK ROYALTIES ANNOUNCES 2023 RESULTS INCLUDING RECORD ANNUAL & QUARTERLY FUNDS FROM OPERATIONS

Freegold Announces Start of 2024 Drilling Program at Golden Summit

Acquisition of Bengal Mining - Highly Prospective Lithium Projects in Brazil’s Lithium Valley

Galan Signs Pivotal Commercial Agreement with Catamarca Government to Commercialise Lithium Chloride Concentrate

More Press Releases
Trending Companies

Galan Lithium

GLN:AU

International Graphite

IG6:AU

Heritage Mining

HML:CC

Helium Evolution

HEVI:CA
More Companies
Trending Reports

Lithium Outlook for Australia

2024 Gold Outlook Report

2024 Copper Market Outlook (Australia Ed.)

2024 Lithium Market Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Hemostemix Inc.

TSXV:HEM
Press Releases

Hemostemix Announces Private Placement for Up to C$3 Million

Hemostemix Reaches Milestone in the ACP-01 Phase 2 Critical Limb Ischemia Clinical Trial

Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial

Hemostemix Inc is a clinical-stage biotechnology company. The company's principal business activity is to develop, manufacture, and commercialize blood-derived cell therapies for medical conditions. Its technology platform for developing autologous cell therapies is for the treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.

×